Firefly Neuroscience is trading at $1.01, down 6.05%, after no clear company-specific catalyst was identified for August 21, 2026.
- Recent disclosures included second-quarter results filed August 11 and shareholder-approved plan changes; neither directly explains todayβs decline.
- Broader markets are higher pre-market, making a market-wide explanation less compelling.
- Catalyst remains unclear; monitor for delayed filings or announcements.